NewsBenzinga제브라 테라퓨틱스, CHMP가 니만-피크병 C형 치료제 아리모클로몰의 MAA에 대해 부정적 의견 채택 발표···유럽위원회, 67일 이내 최종 결정 예상 제브라 테라퓨틱스, CHMP가 니만-피크병 C형 치료제 아리모클로몰의 MAA에 대해 부정적 의견 채택 발표···유럽위원회, 67일 이내 최종 결정 예상 Benzinga 2026.11.13 11:30 (GMT+0) Open on Benzinga Other news Soluna Holdings, Inc. (SLNH) Q3 2026 Earnings Call Transcript ‘The Odds Are Almost Zero’: Scott Galloway Doesn’t See Jensen Huang Returning to Nvidia Analysis: Hyperliquid's Stock and Commodity Trading Revenue Grows 6x, Reducing Reliance on Crypto Market Grayscale: Multiple Factors Have Turned Crypto Valuations Oversold; Current Levels Are a Medium- to Long-Term Buying Opportunity for Bitcoin Bitcoin Lightning Network Developers Patch LND Flaw That Could Wipe Payment Records After Node Restart Canton Strategic Holdings Q3 Revenue of $3.05M, Net Loss Widens to $35.1M
Analysis: Hyperliquid's Stock and Commodity Trading Revenue Grows 6x, Reducing Reliance on Crypto Market
Grayscale: Multiple Factors Have Turned Crypto Valuations Oversold; Current Levels Are a Medium- to Long-Term Buying Opportunity for Bitcoin
Bitcoin Lightning Network Developers Patch LND Flaw That Could Wipe Payment Records After Node Restart